The Reporting of Patient-reported Outcomes in Studies of Patients with Rheumatoid Arthritis: A Systematic Review of 250 Articles

被引:33
作者
Kilic, Levent
Erden, Abdulsamet [1 ]
Bingham, Clifton O., III [2 ]
Gossec, Laure [3 ,4 ]
Kalyoncu, Umut [1 ,2 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Internal Med, Div Rheumatol, Ankara, Turkey
[2] Johns Hopkins Univ, Dept Med, Div Rheumatol, Baltimore, MD USA
[3] Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, GRC UPMC EEMOIS 08, Paris, France
[4] Hop La Pitie Salpetriere, Dept Rheumatol, Paris, France
关键词
RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; PATIENT-REPORTED; OUTCOMES MEASURES; COLLEGE-OF-RHEUMATOLOGY; DISEASE-ACTIVITY INDEX; AMERICAN-COLLEGE; CLINICAL-PRACTICE; ACTIVITY SCORE; VALIDATION; QUALITY; TRIALS; RECOMMENDATIONS; INSTRUMENTS;
D O I
10.3899/jrheum.151177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Patient-reported outcomes ( PRO) in rheumatoid arthritis ( RA) provide important information regarding disease effect. The study objective was to assess the frequency of PRO use in recent RA studies and compare results with a previous systematic review ( SR) in 2005-2007. Methods. An SR was performed in PubMed MEDLINE ( January 2015). Publications were identified using these MEdical Subject Headings terms: "arthritis, rheumatoid" with a limitation to "humans," " all adults: 19+ years," " English," " published in the last 2 years," and " clinical trials." All studies were assessed, whatever their designs. All PRO reported in publications were classified according to general domains of health by 2 authors. Statistics were descriptive. Results. Two hundred fifty articles were analyzed. Of them, 113 ( 45.2%) were randomized controlled trials; 138 different PRO were reported. The most frequent PRO, similar to the 2007 SR, were function ( 68.0%), pain ( 40.0%), patient's global assessment ( 49.2%), and health-related quality of life ( 18.4%). Fatigue ( 14.4%), morning stiffness ( 10.0%), psychological status ( 9.6%), productivity losses ( 6.4%), utility ( 5.2%), sleep disturbance ( 2.4%), and coping ( 2.0%) were rarely reported. Although frequent domains were reported using well-validated questionnaires, the others were reported using heterogeneous questionnaires. Conclusion. The PRO collected and reported in RA studies are remarkably consistent with those seen in 2005-2007, and reflect the existing RA Core Set measures. Other domains of health prioritized by patients including fatigue, psychological status, productivity losses, sleep disturbance, and coping remain rarely reported. Further, heterogeneity in outcome measures used presents challenges in interpreting true disease effect and response to therapy.
引用
收藏
页码:1300 / 1305
页数:6
相关论文
共 27 条
[21]   ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research [J].
Reeve, Bryce B. ;
Wyrwich, Kathleen W. ;
Wu, Albert W. ;
Velikova, Galina ;
Terwee, Caroline B. ;
Snyder, Claire F. ;
Schwartz, Carolyn ;
Revicki, Dennis A. ;
Moinpour, Carol M. ;
McLeod, Lori D. ;
Lyons, Jessica C. ;
Lenderking, William R. ;
Hinds, Pamela S. ;
Hays, Ron D. ;
Greenhalgh, Joanne ;
Gershon, Richard ;
Feeny, David ;
Fayers, Peter M. ;
Cella, David ;
Brundage, Michael ;
Ahmed, Sara ;
Aaronson, Neil K. ;
Butt, Zeeshan .
QUALITY OF LIFE RESEARCH, 2013, 22 (08) :1889-1905
[22]   Patient Perspective of Measuring Treatment Efficacy: The Rheumatoid Arthritis Patient Priorities for Pharmacologic Interventions Outcomes [J].
Sanderson, T. ;
Morris, M. ;
Calnan, M. ;
Richards, P. ;
Hewlett, S. .
ARTHRITIS CARE & RESEARCH, 2010, 62 (05) :647-656
[23]   Remission of Rheumatoid Arthritis in Clinical Practice Application of the American College of Rheumatology/European League Against Rheumatism 2011 Remission Criteria [J].
Shahouri, Shadi H. ;
Michaud, Kaleb ;
Mikuls, Ted R. ;
Caplan, Liron ;
Shaver, Timothy S. ;
Anderson, James D. ;
Weidensaul, David N. ;
Busch, Ruth E. ;
Wang, Shirley ;
Wolfe, Frederick .
ARTHRITIS AND RHEUMATISM, 2011, 63 (11) :3204-3215
[24]   2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis [J].
Singh, Jasvinder A. ;
Furst, Daniel E. ;
Bharat, Aseem ;
Curtis, Jeffrey R. ;
Kavanaugh, Arthur F. ;
Kremer, Joel M. ;
Moreland, Larry W. ;
O'Dell, James ;
Winthrop, Kevin L. ;
Beukelman, Timothy ;
Bridges, S. Louis, Jr. ;
Chatham, W. Winn ;
Paulus, Harold E. ;
Suarez-Almazor, Maria ;
Bombardier, Claire ;
Dougados, Maxime ;
Khanna, Dinesh ;
King, Charles M. ;
Leong, Amye L. ;
Matteson, Eric L. ;
Schousboe, John T. ;
Moynihan, Eileen ;
Kolba, Karen S. ;
Jain, Archana ;
Volkmann, Elizabeth R. ;
Agrawal, Harsh ;
Bae, Sangmee ;
Mudano, Amy S. ;
Patkar, Nivedita M. ;
Saag, Kenneth G. .
ARTHRITIS CARE & RESEARCH, 2012, 64 (05) :625-639
[25]   A simplified disease activity index for rheumatoid arthritis for use in clinical practice [J].
Smolen, JS ;
Breedveld, FC ;
Schiff, MH ;
Kalden, JR ;
Emery, P ;
Eberl, G ;
van Riel, PL ;
Tugwell, P .
RHEUMATOLOGY, 2003, 42 (02) :244-257
[26]   The patient perspective on remission in rheumatoid arthritis: "You've got limits, but you're back to being you again' [J].
van Tuyl, Lilian H. D. ;
Hewlett, Sarah ;
Sadlonova, Martina ;
Davis, Bev ;
Flurey, Caroline ;
Hoogland, Wijnanda ;
Kirwan, John ;
Sanderson, Tessa ;
van Schaardenburg, Dirkjan ;
Scholte-Voshaar, Marieke ;
Smolen, Josef ;
Stamm, Tanja ;
Boers, Maarten .
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) :1004-1010
[27]   Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis - Comparison with the preliminary American College of Rheumatology and the World Health Organization International League Against Rheumatism criteria [J].
vanGestel, AM ;
Prevoo, MLL ;
vantHof, MA ;
vanRijswijk, MH ;
vandePutte, LBA ;
vanRiel, PLCM .
ARTHRITIS AND RHEUMATISM, 1996, 39 (01) :34-40